Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.
暂无分享，去创建一个
A. Dejean | V. Pancaldi | J. Mazières | H. Avet-Loiseau | L. Dupré | A. Saoudi | Camille Guillerey | M. Smyth | M. Cuisinier | E. Morandi | E. Verhoeyen | I. Das | G. Gaud | S. Goriely | T. Bald | M. Ayyoub | Alejandra Martinez | S. Kassem | N. Carrié | L. Martinet | Clara-Maria Scarlata | Ashmitha Sundarrajan | M. Peres | Lea Lemaitre | marie-Veronique Joubert | M. Braun | Marianne Weulersse | Elisa Brauns | L. Buisson | S. Mahéo | Laura Do Souto | Andrea C. Pichler | Assia Asrir | Marie Le Moine | A.Sanchez Agesta | Thomas Gossye | Laura do Souto | Ludovic Martinet | Matthias Braun